Risk factors for a first thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study

Amelia Ruffatti, Teresa Del Ross, Manuela Ciprian, Maria T. Bertero, Salvatore Sciascia, Salvatore Scarpato, Carlomaurizio Montecucco, Silvia Rossi, Paola Caramaschi, Domenico Biasi, Andrea Doria, Mariaelisa Rampudda, Monica Nuzzo, Fabio Fischetti, Ugo Picillo, Antonio Brucato, Elisa Salvan, Vittorio Pengo, Pierluigi Meroni, Tincani Angela Tincani

Research output: Contribution to journalArticle

Abstract

Objectives To assess risk factors for a first thrombotic event in confirmed antiphospholipid (aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments. Methods Inclusion criteria were age 18-65 years, no history of thrombosis and two consecutive positive aPL results. Demographic, laboratory and clinical parameters were collected at enrolment, once a year during the follow-up and at the time of the thrombotic event, whenever that occurred. Results 258 subjects were prospectively observed between October 2004 and October 2008. The mean±SD follow-up was 35.0±11.9 months (range 1-48). A first thrombotic event (9 venous, 4 arterial and 1 transient ischaemic attack) occurred in 14 subjects (5.4%, annual incidence rate 1.86%). Hypertension and lupus anticoagulant (LA) were significantly predictive of thrombosis (both at p

Original languageEnglish
Pages (from-to)1083-1086
Number of pages4
JournalAnnals of the Rheumatic Diseases
Volume70
Issue number6
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Lupus Coagulation Inhibitor
Antiphospholipid Antibodies
Thrombosis
Transient Ischemic Attack
Demography
Hypertension
Incidence

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

Ruffatti, A., Del Ross, T., Ciprian, M., Bertero, M. T., Sciascia, S., Scarpato, S., ... Angela Tincani, T. (2011). Risk factors for a first thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study. Annals of the Rheumatic Diseases, 70(6), 1083-1086. https://doi.org/10.1136/ard.2010.142042

Risk factors for a first thrombotic event in antiphospholipid antibody carriers : A prospective multicentre follow-up study. / Ruffatti, Amelia; Del Ross, Teresa; Ciprian, Manuela; Bertero, Maria T.; Sciascia, Salvatore; Scarpato, Salvatore; Montecucco, Carlomaurizio; Rossi, Silvia; Caramaschi, Paola; Biasi, Domenico; Doria, Andrea; Rampudda, Mariaelisa; Nuzzo, Monica; Fischetti, Fabio; Picillo, Ugo; Brucato, Antonio; Salvan, Elisa; Pengo, Vittorio; Meroni, Pierluigi; Angela Tincani, Tincani.

In: Annals of the Rheumatic Diseases, Vol. 70, No. 6, 06.2011, p. 1083-1086.

Research output: Contribution to journalArticle

Ruffatti, A, Del Ross, T, Ciprian, M, Bertero, MT, Sciascia, S, Scarpato, S, Montecucco, C, Rossi, S, Caramaschi, P, Biasi, D, Doria, A, Rampudda, M, Nuzzo, M, Fischetti, F, Picillo, U, Brucato, A, Salvan, E, Pengo, V, Meroni, P & Angela Tincani, T 2011, 'Risk factors for a first thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study', Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 1083-1086. https://doi.org/10.1136/ard.2010.142042
Ruffatti, Amelia ; Del Ross, Teresa ; Ciprian, Manuela ; Bertero, Maria T. ; Sciascia, Salvatore ; Scarpato, Salvatore ; Montecucco, Carlomaurizio ; Rossi, Silvia ; Caramaschi, Paola ; Biasi, Domenico ; Doria, Andrea ; Rampudda, Mariaelisa ; Nuzzo, Monica ; Fischetti, Fabio ; Picillo, Ugo ; Brucato, Antonio ; Salvan, Elisa ; Pengo, Vittorio ; Meroni, Pierluigi ; Angela Tincani, Tincani. / Risk factors for a first thrombotic event in antiphospholipid antibody carriers : A prospective multicentre follow-up study. In: Annals of the Rheumatic Diseases. 2011 ; Vol. 70, No. 6. pp. 1083-1086.
@article{8258ef1145984822b0167ada8194d333,
title = "Risk factors for a first thrombotic event in antiphospholipid antibody carriers: A prospective multicentre follow-up study",
abstract = "Objectives To assess risk factors for a first thrombotic event in confirmed antiphospholipid (aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments. Methods Inclusion criteria were age 18-65 years, no history of thrombosis and two consecutive positive aPL results. Demographic, laboratory and clinical parameters were collected at enrolment, once a year during the follow-up and at the time of the thrombotic event, whenever that occurred. Results 258 subjects were prospectively observed between October 2004 and October 2008. The mean±SD follow-up was 35.0±11.9 months (range 1-48). A first thrombotic event (9 venous, 4 arterial and 1 transient ischaemic attack) occurred in 14 subjects (5.4{\%}, annual incidence rate 1.86{\%}). Hypertension and lupus anticoagulant (LA) were significantly predictive of thrombosis (both at p",
author = "Amelia Ruffatti and {Del Ross}, Teresa and Manuela Ciprian and Bertero, {Maria T.} and Salvatore Sciascia and Salvatore Scarpato and Carlomaurizio Montecucco and Silvia Rossi and Paola Caramaschi and Domenico Biasi and Andrea Doria and Mariaelisa Rampudda and Monica Nuzzo and Fabio Fischetti and Ugo Picillo and Antonio Brucato and Elisa Salvan and Vittorio Pengo and Pierluigi Meroni and {Angela Tincani}, Tincani",
year = "2011",
month = "6",
doi = "10.1136/ard.2010.142042",
language = "English",
volume = "70",
pages = "1083--1086",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - Risk factors for a first thrombotic event in antiphospholipid antibody carriers

T2 - A prospective multicentre follow-up study

AU - Ruffatti, Amelia

AU - Del Ross, Teresa

AU - Ciprian, Manuela

AU - Bertero, Maria T.

AU - Sciascia, Salvatore

AU - Scarpato, Salvatore

AU - Montecucco, Carlomaurizio

AU - Rossi, Silvia

AU - Caramaschi, Paola

AU - Biasi, Domenico

AU - Doria, Andrea

AU - Rampudda, Mariaelisa

AU - Nuzzo, Monica

AU - Fischetti, Fabio

AU - Picillo, Ugo

AU - Brucato, Antonio

AU - Salvan, Elisa

AU - Pengo, Vittorio

AU - Meroni, Pierluigi

AU - Angela Tincani, Tincani

PY - 2011/6

Y1 - 2011/6

N2 - Objectives To assess risk factors for a first thrombotic event in confirmed antiphospholipid (aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments. Methods Inclusion criteria were age 18-65 years, no history of thrombosis and two consecutive positive aPL results. Demographic, laboratory and clinical parameters were collected at enrolment, once a year during the follow-up and at the time of the thrombotic event, whenever that occurred. Results 258 subjects were prospectively observed between October 2004 and October 2008. The mean±SD follow-up was 35.0±11.9 months (range 1-48). A first thrombotic event (9 venous, 4 arterial and 1 transient ischaemic attack) occurred in 14 subjects (5.4%, annual incidence rate 1.86%). Hypertension and lupus anticoagulant (LA) were significantly predictive of thrombosis (both at p

AB - Objectives To assess risk factors for a first thrombotic event in confirmed antiphospholipid (aPL) antibody carriers and to evaluate the efficacy of prophylactic treatments. Methods Inclusion criteria were age 18-65 years, no history of thrombosis and two consecutive positive aPL results. Demographic, laboratory and clinical parameters were collected at enrolment, once a year during the follow-up and at the time of the thrombotic event, whenever that occurred. Results 258 subjects were prospectively observed between October 2004 and October 2008. The mean±SD follow-up was 35.0±11.9 months (range 1-48). A first thrombotic event (9 venous, 4 arterial and 1 transient ischaemic attack) occurred in 14 subjects (5.4%, annual incidence rate 1.86%). Hypertension and lupus anticoagulant (LA) were significantly predictive of thrombosis (both at p

UR - http://www.scopus.com/inward/record.url?scp=79955815184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955815184&partnerID=8YFLogxK

U2 - 10.1136/ard.2010.142042

DO - 10.1136/ard.2010.142042

M3 - Article

C2 - 21285115

AN - SCOPUS:79955815184

VL - 70

SP - 1083

EP - 1086

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -